Kommineni N - Search Results

1

Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.

Mahira S, Kommineni N, Husain GM, Khan W. Mahira S, et al. Among authors: kommineni n. Biomed Pharmacother. 2019 Feb;110:803-817. doi: 10.1016/j.biopha.2018.11.145. Epub 2018 Dec 13. Biomed Pharmacother. 2019. PMID: 30554119 Free article.

2

Liposomal Formulations in Clinical Use: An Updated Review.

Bulbake U, Doppalapudi S, Kommineni N, Khan W. Bulbake U, et al. Among authors: kommineni n. Pharmaceutics. 2017 Mar 27;9(2):12. doi: 10.3390/pharmaceutics9020012. Pharmaceutics. 2017. PMID: 28346375 Free PMC article. Review.

3

Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.

Muntimadugu E, Kommineni N, Khan W. Muntimadugu E, et al. Among authors: kommineni n. Pharmacol Res. 2017 Dec;126:109-122. doi: 10.1016/j.phrs.2017.05.010. Epub 2017 May 13. Pharmacol Res. 2017. PMID: 28511988 Review.

4

Non-polymer drug-eluting coronary stents.

Kommineni N, Saka R, Khan W, Domb AJ. Kommineni N, et al. Drug Deliv Transl Res. 2018 Aug;8(4):903-917. doi: 10.1007/s13346-017-0414-3. Drug Deliv Transl Res. 2018. PMID: 28799125 Review.

5

Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.

Pandi P, Jain A, Kommineni N, Ionov M, Bryszewska M, Khan W. Pandi P, et al. Among authors: kommineni n. Int J Pharm. 2018 Oct 25;550(1-2):240-250. doi: 10.1016/j.ijpharm.2018.08.024. Epub 2018 Aug 27. Int J Pharm. 2018. PMID: 30165098

6

Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer.

Kommineni N, Saka R, Bulbake U, Khan W. Kommineni N, et al. Chem Phys Lipids. 2019 Nov;224:104707. doi: 10.1016/j.chemphyslip.2018.11.009. Epub 2018 Dec 4. Chem Phys Lipids. 2019. PMID: 30521787

7

Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.

Bulbake U, Kommineni N, Ionov M, Bryszewska M, Khan W. Bulbake U, et al. Among authors: kommineni n. Pharm Dev Technol. 2020 Jan;25(1):9-19. doi: 10.1080/10837450.2019.1567763. Epub 2019 Oct 31. Pharm Dev Technol. 2020. PMID: 30633621

8

Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.

Sathe P, Saka R, Kommineni N, Raza K, Khan W. Sathe P, et al. Among authors: kommineni n. Drug Dev Ind Pharm. 2019 May;45(5):826-838. doi: 10.1080/03639045.2019.1576722. Epub 2019 Feb 14. Drug Dev Ind Pharm. 2019. PMID: 30764674

9

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects.

Kommineni N, Mahira S, Domb AJ, Khan W. Kommineni N, et al. Pharmaceutics. 2019 Mar 25;11(3):141. doi: 10.3390/pharmaceutics11030141. Pharmaceutics. 2019. PMID: 30934535 Free PMC article.

10

Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib.

Pathade AD, Kommineni N, Bulbake U, Thummar MM, Samanthula G, Khan W. Pathade AD, et al. Among authors: kommineni n. AAPS PharmSciTech. 2019 Aug 6;20(7):276. doi: 10.1208/s12249-019-1468-y. AAPS PharmSciTech. 2019. PMID: 31388783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters